Dexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities in the U.S.

Learn more about whether Glaukos Corporation or iRhythm Technologies, Inc. is a better investment based on AAII's A+ Investor ...

The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio ...

CEO Quentin Blackford highlighted a 24% year-over-year revenue growth in Q4 2024, driven by record demand and account openings for Zio products. He emphasized increased volume from primary care ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...